Clinical
How Atrium Health researchers are making clinical trials more accessible to underserved populations
…Cancer Center are making it easier for racial and ethnic minorities and underserved patients in North Carolina, Virginia and West Virginia t...
Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment
[June 14, 2022]
Antidote Technologies (Antidote), a patient-centric digital engagement company focused on connecting patients with clinical res...
Clinical practice guidelines miss shot to address race, ethnicity
By Ronnie Cohen
(Reuters Health) – The vast majority of pediatric clinical
practice guidelines fail to mention race or ethnicity, and m...
Improving Diversity In Clinical Trials With A Community-Based Approach
By Nick Davies, EY-Parthenon
How we address health disparities, especially regarding race and ethnicity, is critical to improving health o...
Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity
Purpose:
Stereotactic ablative radiotherapy (SABR) has demonstrated clinical benefit in oligometastatic prostate cancer. However, th...
Accrual and retention of diverse patients in psychosocial cancer clinical trials
Background:
Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
